CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-30 | Herhalt Johann Michael Director | Grant or award · Restricted Stock Units | +62,657 | 62,657 | ||
| 2026-07-30 | Hopkinson David G. Director | Grant or award · Restricted Stock Units | +62,657 | 62,657 | ||
| 2026-07-29 | SIMON IRWIN D President and CEO | Option exercise | +428,448 | 911,097 | ||
| 2026-07-29 | SIMON IRWIN D President and CEO | Shares withheld for taxes | −227,078 | $3.99 | $906K | 684,019 |
| 2026-07-29 | SIMON IRWIN D President and CEO | Option exercise · Restricted Stock Units | −428,448 | 428,448 | ||
| 2026-07-29 | SIMON IRWIN D President and CEO | Grant or award · Restricted Stock Units | +1,289,211 | 1,289,211 | ||
| 2026-07-29 | Merton Carl A Chief Financial Officer | Option exercise | +60,417 | 152,467 | ||
| 2026-07-29 | Merton Carl A Chief Financial Officer | Shares withheld for taxes | −30,209 | $3.99 | $121K | 122,258 |
| 2026-07-29 | Merton Carl A Chief Financial Officer | Option exercise · Restricted Stock Units | −60,417 | 93,685 | ||
| 2026-07-29 | Merton Carl A Chief Financial Officer | Grant or award · Restricted Stock Units | +180,302 | 281,901 | ||
| 2026-07-29 | Gendel Mitchell Global General Counsel | Option exercise | +87,440 | 157,269 | ||
| 2026-07-29 | Gendel Mitchell Global General Counsel | Shares withheld for taxes | −46,344 | $3.99 | $185K | 110,925 |
| 2026-07-29 | Gendel Mitchell Global General Counsel | Option exercise · Restricted Stock Units | −87,440 | 87,440 | ||
| 2026-07-29 | Gendel Mitchell Global General Counsel | Grant or award · Restricted Stock Units | +263,108 | 263,108 | ||
| 2026-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +93,685 | 176,163 | ||
| 2026-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −49,654 | $3.99 | $198K | 126,509 |
| 2026-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Restricted Stock Units | −93,685 | 93,685 | ||
| 2026-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Grant or award · Restricted Stock Units | +281,901 | 281,901 | ||
| 2026-07-29 | Persofsky Renah Director | Option exercise | +43,104 | 176,909 | ||
| 2026-07-29 | Persofsky Renah Director | Shares withheld for taxes | −21,552 | $3.99 | $86K | 155,357 |
Page 3 of 35 · 686 trades